Seeking Alpha
View as an RSS Feed

Wall Street Teacher  

View Wall Street Teacher's Comments BY TICKER:
Latest  |  Highest rated
  • CorMedix: High Probability Of Phase 3 Success? [View article]
    As the longest term CRMD Bull (Check my track record and articles< I find the recent selling pressure both understandable and inevitable. The stock had a great run and now they have an ATM running, The last two presentations by the CEO were lackluster(I am being charitable). These are the times to evaluate if Good Banker/good drug/ trumps uncertainty and innuendo. I still believe this is sold at a SIGNIFICANT PREMIUM to current SP.
    May 25, 2015. 02:43 PM | 3 Likes Like |Link to Comment
  • CorMedix: Making Progress In Both EU Commercial And U.S. Regulatory Fronts [View article]
    Yet another poorly written attack piece. I wish they would have at least gotten the name correct(Coremedix???) As for the Dr. Rodenwald innuendo----SILLY. This is Elliot's show and they have brought in Evercore to find a home for little CRMD.
    Apr 13, 2015. 05:43 PM | Likes Like |Link to Comment
  • CorMedix: High Probability Of Phase 3 Success? [View article]
    Increased market size projection and dramatic COG reduction announced this week make this an even more valuable asset. Evercore should preside over a VERY lively auction.
    Apr 10, 2015. 06:51 PM | 3 Likes Like |Link to Comment
  • Borrow Costs Elevated On CorMedix [View article]
    I would only be guessing.....
    Apr 4, 2015. 11:07 PM | Likes Like |Link to Comment
  • CorMedix: Up Too Far Too Fast [View article]
    Hi-

    Thank you for the kind words. I read constantly and when I think a company has potential I talk with management extensively. Finding and able and honest management team is perhaps the most important aspect. I have seen great products sunk by poor execution.

    As for the deal; closing usually take several weeks from the announcement of an agreement. I would be very surprised if this has not been sold (deal agreed to) within 45 days. We got lucky on Neutrolin's garnering of QIDP since infection has now moved front and center. This product has broad applicability and a 10.5 year exclusivity period. It is simply to juicy of an asset to pass up. I expect a faitly robust auction and thank God that Elliot brought in Evercore. They are top shelf bankers and will find us a good deal.

    Good Luck,

    WST
    Apr 4, 2015. 08:55 PM | 2 Likes Like |Link to Comment
  • CorMedix: Up Too Far Too Fast [View article]
    I am not even sure if the decision as to whether or not to negotiate is till in CRMDs hands. I think the Gremanic Trio may have lost their window to settle. Any of the majors will quickly close the manufacturing cost gap and will initiate an endless series of lawsuits. This will soon get very ugly. As for may, I think CRMD is gone by then so I am not sure who from the predecessor shows up in court.
    Apr 3, 2015. 08:27 PM | 2 Likes Like |Link to Comment
  • Borrow Costs Elevated On CorMedix [View article]
    Stunningly good data set at this weekend's conference. Wonderful asset with applicability in many healthcare settings. All the more reason that this will be a VERY competitive auction. I think this soon holds a nine handle and then we continue our march upward.
    Mar 30, 2015. 05:42 PM | 2 Likes Like |Link to Comment
  • Keryx: The Company That Saves More Money Than Its Market Cap [View article]
    I feel the same way about CRMD. Another "cost saver" in the catheter care space. The company is likely on the block since Elliot Management has brought in Evercore to "explore strategic options". I always thought they would be a good fit for KERYX but the recent management shakeup means Keryx is more likely focused on the rollout than expanding its renal portfolio


    http://seekingalpha.co...
    Mar 22, 2015. 04:31 PM | Likes Like |Link to Comment
  • DaVita: Sometimes The Money Is Lying On The Street [View article]
    http://seekingalpha.co...

    This one's for sale in the catheter space. I wonder if DaVita or Fresenius are in the mix?
    Mar 22, 2015. 04:28 PM | Likes Like |Link to Comment
  • CorMedix: An Interesting Play In The Catheter Care Space [View article]
    Interesting hit piece from TruthSweeper(OK, StreetSweeper). I AM NOY BUYING their half-truths and innuendo. Registration of shares does not mean same will be sold. Elliot is the largest shareholder and they have brought in Evercore for a reason. Positive NUMP data in EU is far in excess of PHIII bar.. This gets sold...........
    Mar 22, 2015. 04:26 PM | Likes Like |Link to Comment
  • CorMedix Update: Setting A New Standard For Catheter Care [View article]
    Interesting "article" this week from StreetSweeper. It seemed more than a bit disingenuous---perhaps even designed to mislead. Then again, who can ever judge another's intent? Here is the face behind the TruthSweeper. Draw your own conclusions:

    Hunter Adams, a member of the expert advisory board for The Street Sweeper, understands stock manipulation firsthand. Adams entered the securities industry 15 years ago with a focus on high-risk penny stocks. He quickly became an expert at establishing shell corporations, executing reverse mergers and selling both equity and convertible debt in speculative small-cap companies. His career ended in 2001, when government investigators accused him of manipulating worthless penny stocks. He pled guilty to two conspiracy charges -- for securities fraud and money laundering -- and served time in prison for his crimes. Years later, he pled guilty to racketeering charges, fully cooperated with the government and accepted full responsibility for his actions. Today, he has embraced a life of reform and now hopes to help protect the public by exposing others who tread in the same murky waters he once swam in. To contact him directly, please send an email to hunter@thestreetsweepe...
    Mar 21, 2015. 01:47 PM | Likes Like |Link to Comment
  • CorMedix: Up Too Far Too Fast [View article]
    Here is the face behind the TruthSweeper. Draw your own conclusions:

    Hunter Adams, a member of the expert advisory board for The Street Sweeper, understands stock manipulation firsthand. Adams entered the securities industry 15 years ago with a focus on high-risk penny stocks. He quickly became an expert at establishing shell corporations, executing reverse mergers and selling both equity and convertible debt in speculative small-cap companies. His career ended in 2001, when government investigators accused him of manipulating worthless penny stocks. He pled guilty to two conspiracy charges -- for securities fraud and money laundering -- and served time in prison for his crimes. Years later, he pled guilty to racketeering charges, fully cooperated with the government and accepted full responsibility for his actions. Today, he has embraced a life of reform and now hopes to help protect the public by exposing others who tread in the same murky waters he once swam in. To contact him directly, please send an email to hunter@thestreetsweeper
    Mar 21, 2015. 01:45 PM | 2 Likes Like |Link to Comment
  • Seeking Alpha's Biotech Weekly: Deeper Looks At Orexigen, Pharmacyclics, And Acadia [View article]
    StreetSweeper issued a very questionable "article" re: CRMD this week. Here is the face behind the TruthSweeper. Draw your own conclusions:

    Hunter Adams, a member of the expert advisory board for The Street Sweeper, understands stock manipulation firsthand. Adams entered the securities industry 15 years ago with a focus on high-risk penny stocks. He quickly became an expert at establishing shell corporations, executing reverse mergers and selling both equity and convertible debt in speculative small-cap companies. His career ended in 2001, when government investigators accused him of manipulating worthless penny stocks. He pled guilty to two conspiracy charges -- for securities fraud and money laundering -- and served time in prison for his crimes. Years later, he pled guilty to racketeering charges, fully cooperated with the government and accepted full responsibility for his actions. Today, he has embraced a life of reform and now hopes to help protect the public by exposing others who tread in the same murky waters he once swam in. To contact him directly, please send an email to hunter@thestreetsweepe...
    Mar 21, 2015. 01:44 PM | Likes Like |Link to Comment
  • Borrow Costs Elevated On CorMedix [View article]
    Here is the face behind the TruthSweeper. Draw your own conclusions:




    Hunter Adams, a member of the expert advisory board for The Street Sweeper, understands stock manipulation firsthand. Adams entered the securities industry 15 years ago with a focus on high-risk penny stocks. He quickly became an expert at establishing shell corporations, executing reverse mergers and selling both equity and convertible debt in speculative small-cap companies. His career ended in 2001, when government investigators accused him of manipulating worthless penny stocks. He pled guilty to two conspiracy charges -- for securities fraud and money laundering -- and served time in prison for his crimes. Years later, he pled guilty to racketeering charges, fully cooperated with the government and accepted full responsibility for his actions. Today, he has embraced a life of reform and now hopes to help protect the public by exposing others who tread in the same murky waters he once swam in. To contact him directly, please send an email to hunter@thestreetsweepe...
    Mar 21, 2015. 09:05 AM | 2 Likes Like |Link to Comment
  • Borrow Costs Elevated On CorMedix [View article]
    Elliot is not an investment bank. I am done wasting time in senseless back and forth. Good luck.
    Mar 18, 2015. 07:04 PM | 3 Likes Like |Link to Comment
COMMENTS STATS
467 Comments
284 Likes